Eligens.io is a pioneering digital health company transforming preventive healthcare globally. Our cutting-edge approach merges data-driven insights with tailored health strategies, targeting serious disease prevention. Were active in over 70 countries, with a special focus on regions like Latin America, Central Asia, and Europe.
Our digital health platform is our cornerstone, engaging customers with a unique, recurring revenue model. Key offerings include:
-- DNA Ancestry Testing: A viral product promoting social media engagement and organic growth through shared ancestral discoveries.
-- Genetic Health Risk Analysis: Utilizing DNA data to pinpoint individual health risks and the need for personalized prevention.
-- Personalized Prevention Plans: Customized plans involving blood tests, consultations, and medication, based on genetic analysis and in alignment with clinical guidelines.
Our platform employs AI and machine learning for DNA test analysis, questionnaires, and medical data processing, to continuously evaluate disease risks and suggest prevention and treatment strategies. This innovative method not only provides actionable insights for customers but also aids drug development and research.
Experiencing rapid customer growth, Eligens validates the success of its business model. The team, led by Founder and CEO Valery Ilinsky, a biochemistry expert, is committed to delivering groundbreaking health solutions.
Eligens, headquartered in Latvia, operates divisions in Brazil, Armenia, and Hong Kong. More than a healthcare company, we are a tech-driven enterprise empowering individuals to manage their health proactively. Join us in our quest to redefine preventive healthcare, making it more accessible and effective across the globe.
